Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 20,443

Document Document Title
WO/2018/189060A1
The invention comprises novel chiral metal complex compounds of the formula (I) wherein M, PR2, R3 and R4 are outlined in the description, its stereoisomers, in the form as a neutral complex or a complex cation with a suitable counter io...  
WO/2018/190516A1
The present invention provides a novel heterocyclic compound and an organic light-emitting element utilizing same.  
WO/2018/188795A1
The present invention relates to sulfonamide-, sulfinamide- or sulfonimidamide containing compounds which bind to the liver X receptor (LXRa and/or LXRß) and act preferably as inverse agonists of LXR.  
WO/2018/181054A1
Provided are: an organic semiconductor element in which an organic semiconductor layer comprises a compound represented by formula (1) and/or a compound represented by formula (2), or a polymer having either of the structures represented...  
WO/2018/177151A1
Compounds such as vidofludimus and its analogues useful in modulating the activity of nuclear receptor FXR. Also disclosed are the methods for treating FXR-mediated disease or process in a mammal, comprising administering to the mammal a...  
WO/2018/183411A1
Compounds of formula (I) as inhibitors of DCNl and compositions containing the same are disclosed. Methods of using the DCNl inhibitors in the treatment of diseases and conditions wherein inhibition of DCNl provides a benefit, like oxida...  
WO/2018/172852A1
The present invention includes novel substituted bicyclic compounds, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infections in a patient. In certain embodiments, the compounds and co...  
WO/2018/172423A1
The invention relates to a compound which is an indane derivative according to Formula (I), or a pharmaceutically acceptable salt thereof, [FORMULA (I)] wherein R1, R2, R3, n, R4, p¸ q, L, ׇ, X and m are as defined herein. The compound...  
WO/2018/174293A1
An organic electroluminescence element comprising, in the stated order, an anode, an organic layer, a light-emitting layer, and a cathode, the organic layer including the compound represented in formula (20), and the light-emitting layer...  
WO/2018/173058A1
The present invention provides processes for the preparation of diverse heterocyclic scaffolds from alpha-enaminone building bloc of formula (I).  
WO/2018/169261A1
The present invention provides: a compound capable of enabling high luminous efficiency, a low driving voltage, and an improved lifespan of an element; an organic electric element using the same; and an electronic device thereof.  
WO/2018/168714A1
Provided is an oxime ester compound represented by general formula (Iα) or (Iβ). (In the formulae: R1 to R6 and R101 to R108 each independently denote a group represented by general formula (II), a hydrogen atom, a halogen atom, a nitr...  
WO/2018/170067A1
Provided herein are compositions comprising a compound of Formulas I, II, or III, and compositions a compound comprising a moiety of Formula IV, which are useful for sensitizing and/or activating pro-apoptotic activity of BAX. Methods of...  
WO/2018/164265A1
A compound represented by formula (1) provides an organic electroluminescent element that exhibits exceptional luminous efficiency. (In formula (1), R1-R8, R11-R18, R21, R22, L1, L2, L3, Ar1, and Ar2 are as defined in the description.)  
WO/2018/164545A1
The present invention provides a novel compound and an organic light emitting element using the same.  
WO/2018/160022A1
The present disclosure relates to an organic electroluminescent device. The organic electroluminescent device of the present disclosure comprises a specific combination of a light-emitting layer and an electron transport zone, thereby pr...  
WO/2018/157842A1
The present invention provides a use of 2-(substituted phenylamino)benzoic acid FTO inhibitor in treating leukemia.  
WO/2018/158256A2
The present invention discloses novel compounds which are useful as potassium channel openers, in particular as openers of the Kv7.4 potassium channel. The novel compounds are compounds according to formula (I), wherein - n = 0 or 1, - R...  
WO/2018/157843A1
The preparation method provides 2-(substituted benzene matrix) aromatic formate FTO inhibitor, a preparation method therefor, and applications thereof. Specifically, disclosed in the present invention are a 2-(substituted benzene matrix)...  
WO/2018/157801A1
The present invention relates to a cyano group-substituted fused bicyclic derivative, and a pharmaceutical composition comprising the compound. The compound or the pharmaceutical composition can be used for inhibiting xanthine oxidase an...  
WO/2018/159970A1
The present disclosure relates to an organic electroluminescent device comprising a light-emitting layer and a hole transport zone. By comprising a specific combination of a light-emitting layer and a hole transport zone, it is possible ...  
WO/2018/159650A1
The purpose of the present invention is to provide a compound which has a guanidine skeleton and inhibits the protease activity of MALT1 to exhibit a therapeutic effect or prophylactic effect on autoimmune diseases such as psoriasis. The...  
WO/2018/157981A1
The present invention relates to triarylamine compounds of general formula (I). The present invention further relates to methods for producing said compounds, oligomers, polymers or dendrimers and to formulations containing said compound...  
WO/2018/156046A1
The invention relates to the field of chemical engineering of organic and heteroorganic compounds. The invention also relates to new donor-acceptor oligomers of a general formula (I), where n represents a whole number from 1 to 4 and m r...  
WO/2018/151861A1
Provided herein are methods for determining if a compound has potential efficacy for the treatment for a specific symptom domain of schizophrenia, such as for example, the treatment of a negative symptom of schizophrenia. In addition, pr...  
WO/2018/149850A1
The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic...  
WO/2018/149856A1
The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as tocompositions and ophthalmic ...  
WO/2018/149853A1
The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic...  
WO/2018/149852A1
The present invention relates to novel compounds (I) particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthal...  
WO/2018/146894A1
The problem addressed by this invention is to provide an organic electric field light-emitting element having optimal light-emitting characteristics. This problem is addressed by an organic electric field light-emitting element containin...  
WO/2018/147204A1
Provided is a charge transporting varnish comprising: a charge transporting substance such as an aniline derivative and a thiophene derivative; an onium borate salt such as a compound represented by the formula; and an organic solvent.  
WO/2018/146962A1
The purpose of this invention is to provide an organic electric field light-emitting element having optimal light-emitting characteristics. This problem is solved by an organic electric field light-emitting element having a light-emittin...  
WO/2018/144910A1
The disclosure provides a method of preventing or reducing protein aggregates using combretastatin-A4 (CA4) or an analog thereof. The disclosure also provides methods of reducing the risk, delaying the onset, delaying or slowing the prog...  
WO/2018/139174A1
A fluoroether compound represented by formula (1). R1-R2-CH2-R3-CH2-R4-R5 (1) (In formula (1), R1 and R5 may be the same or different and are each a group having a heteroring, R2 and R4 may be the same or different and are each a divalen...  
WO/2018/140599A1
Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I) or a pharmaceutically acceptable salt, stereoisomer or prodrug thereof, wherein B, Z, Ra, Rb, Rc, R1, L, L1 ...  
WO/2018/139767A1
The present invention provides a novel amine-based compound and an organic light emitting device using the same.  
WO/2018/134510A1
The present invention relates to a method for the preparation of substituted thiolactones of formula (I), substituted thiolactones of formula (I') that can be obtained by implementing said method, the use of substituted thiolactones of f...  
WO/2018/133790A1
The present disclosure relates to heteroaromatic containing organic compounds and methods of use and preparation thereof. The compounds disclosed herein can be used as organic semiconductors.  
WO/2018/135798A1
The present invention provides a novel heterocyclic compound and an organic light emitting element using the same.  
WO/2018/131690A1
[Problem] To provide a novel agrochemical, especially a novel herbicide. [Solution] A ketone or oxime compound represented by formula (1), and a herbicide which contains this compound. (In the formula, B represents B-1 or B-2; Q represen...  
WO/2018/124088A1
Provided are novel pest control agents, in particular, a bactericide and a nematicide. An alkylphenyl-substituted amide compound represented by formula (I) [wherein: G1 stands for a structure represented by G1-2, G1-3, G1-4, etc.; X1 sta...  
WO/2018/122317A1
New Antiviral Drugs and Uses thereof. The present invention relates to a new class of compounds of formula (I) having an antiviral effect and the uses thereof.  
WO/2018/123178A1
The present invention pertains to a fused heteropolycyclic compound represented by general formulas (1) and (2), a method for producing the same, and a method for producing a conductive polymer represented by general formulas (3) and (4)...  
WO/2018/119780A1
A compound having a formula (I) is provided, in which each of A and B is independently and respectively one of formula (II) and (III), given that at least one of A and B comprise an alkynyl, each of R1 and R2 is independently and respect...  
WO/2018/122232A1
Disclosed are sulfonamide compounds with GPR17 modulating properties, which are useful for treating or preventing a variety of CNS and other diseases, in particular for preventing and treating myelinating diseases or disorders.  
WO/2018/115421A1
The present invention discloses compounds of formula (I) that are useful in the treatment of respiratory diseases of animals, especially Bovine or Swine Respiratory disease (BRD and SRD).  
WO/2018/114786A1
The present invention relates to carboxylic acid aromatic amides compounds of general formula (I) as described and defined herein, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds...  
WO/2018/115093A1
The present invention relates to i) a process for treating keratin materials, especially human keratin fibres, comprising the application of an acidic aqueous composition comprising at least one particular thiolactone, in particular for ...  
WO/2018/115091A1
The present invention relates to i) a process for treating keratin materials, in particular human keratin fibres, comprising the application of a composition comprising at least one bisthiolactone of formula (I), in particular for shapin...  
WO/2018/116107A1
Provided are IDO inhibitor compounds of Formula (I) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases ...  

Matches 1 - 50 out of 20,443